StockCIK 1553643

RELMADA THERAPEUTICS, INC. (RLMD): Insider Trades and Fund Holdings

In the past 12 months, RELMADA THERAPEUTICS, INC. insiders reported 4 open-market purchases worth $1.67M and 0 sales worth $0.

4Insider buys, 12 months

$1.67MBought by insiders, 12 months

$0Sold by insiders, 12 months

1Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 11, 2026.

Recent RLMD insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Sep 11	Sep 9	Maged ShenoudaCFO	CFO	▲ BUY	120,200	4.20	$505K	+15%	Form 4 ↗
Sep 11	Sep 9	Sergio TraversaCEO	CEO	▲ BUY	100,000	4.18	$418K	+7.7%	Form 4 ↗
Sep 11	Sep 10	Sergio TraversaCEO	CEO	▲ BUY	100,000	4.10	$410K	+7.1%	Form 4 ↗
Sep 11	Sep 10	Maged ShenoudaCFO	CFO	▲ BUY	79,800	4.25	$339K	+8.7%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
Maged Shenouda	CFO	2	$844K	0	$0	Sep 11, 2026
Sergio Traversa	CEO	2	$828K	0	$0	Sep 11, 2026

Tracked funds that report RLMD

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	57,800	$400K	0.00%	▼ −65.4%

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →